QSAR/QSTR of fluoroquinolones: An example of simultaneous analysis of multiple biological activities using neural network method

European Journal of Medicinal Chemistry

Volumn 33, Issue 7-8, 1998, Pages 647-658

  Tang, Yun ^a,b   Chen, Kai Xian ^a   Jiang, Hua Liang ^a   Ji, Ru Yun ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Fluoroquinolone; Neural networks; Partial least squares (PLS); Quantitative structure activity relationship (QSAR); Quantitative structure toxicity relationship (QSTR)

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; CYTOTOXICITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MODEL; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; TECHNIQUE;

EID: 0032123356     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80023-8     Document Type: Article

References (30)

1. [1] Fujita T., Quant. Struct. Act. Relat. 16 (1997) 107-112.
2. [2] Livingstone D.J., Manallack D.T., Tetko I.V., J. Comput. Aided Mol. Des. 11 (1997) 135-142.
3. [3] Aoyama T., Suzuki Y., Ichikawa H., J. Med. Chem. 33 (1990) 2583-2590.
4. [4] Andrea T.A., Kalayeh H., J. Med. Chem. 34 (1991) 2824-2836.
5. [5] So S.S., Richards W.G., J. Med. Chem. 35 (1992) 3201-3207.
6. [6] Tetko I.V., Luik A.I., Poda G.I., J. Med. Chem. 36 (1993) 811-814.
7. [7] Manallack D.T., Ellis D.D., Livingstone D.J., J. Med. Chem. 37 (1994) 3758-3767.
8. [8] So S.S., Karplus M., J. Med. Chem. 39 (1996) 5246-5256.
9. [9] Hansch C., Acc. Chem. Res. 2 (1969) 232-239.
10. [10] Livingstone D.J.. Ford M.G., in: Ford M.G., Greenwood R.. Brooks G.T., Franke R. (Eds.), Bioactive Compound Design: Possibilities for Industrial Use, Bios, Oxford, 1996, pp. 99-107.
11. [11] Suto M.J., Domagala J.M., Roland G.E., Mailloux G.B., Cohen M.A., J. Med. Chem. 35 (1992) 4745-4750.
12. [12] Von Rosenstiel N., Adam D., Drugs 47 (1994) 872-901.
13. [13] Moreau N.J., Robaux H., Baron L., Tabary X., Antimicrob. Agents Chemother. 34 (1990) 1955-1960.
14. [14] Elsea S.H., Oshcroff N., Nitiss J.L., J. Biol. Chem. 267 (1992) 13150-13153.
15. [15] Chu D.T.W., Fernandes P.B., Antimicrob. Agents Chemother. 33 (1989) 131-135.
16. [16] Bryskier A., Chantot J.F., Drugs 49 (Suppl. 2) (1995) 16-28.
17. [17] Domagala J.M., J. Antimicrob. Chemother. 33 (1994) 685-706.
18. [18] Klopman G., Fereu D., Li J.Y., Rosenkranz H.S., Jacobs M.R., Res. Microbiol. (Paris) 147 (1996) 86-96.
19. [19] SYBYL 6.1, Tripos Associates Inc., St. Louis, 1995.
20. [20] Stewart J.J.P., J. Comput. Aided Mol. Des. 4 (1990) 1-105.
21. [21] Skagerberg B., Bonelli D., Clementi S. et al., Quant. Struct. Act. Relat. 8 (1989) 32-38.
22. [22] Frank I.E., Kalivas J.H., Kowalski B.R., Anal. Chem. 55 (1983) 1800-1804.
23. [23] Cramer III R.D., Bunce J.D., Patterson D.E. et al., Quant. Struct. Act. Relat. 7 (1988) 18-25.
24. [24] Gasteiger J., Zupan J., Angew. Chem. Int. Ed. Engl. 32 (1993) 503-527.
25. [25] Manallack D.T., Livingstone D.J., in: Van de Waterbeemd H. (Ed.), Chemometrics in Molecular Design. VCH, Weinheim, 1995, pp. 293-318.
26. [26] Tetko I.V., Livingstone D.J., Luik A.I., J. Chem. Inf. Comput. Sci. 35 (1995) 826-833.
27. th Symposium on the Interface of Computing Science and Statistics, 1995, pp. 352-360.
28. [28] Hooper D.C., Drugs 49 (Suppl. 2) (1995) 10-15.
29. [29] Tetko I.V., Villa A.E.P., Livingstone D.J., J. Chem. Inf. Comput. Sci. 36 (1996) 794-803.
30. [30] Topliss J.P., Edwards R.P., J. Med. Chem. 22 (1979) 1238-1244.